Skip to main content

Patent Expiry

KPTI: XPOVIO: recorded patent 10519139 expiry

August 14, 2035 · SELINEXOR. BioSniper AI can trace the company-impact path without requiring you to write the research question.

Event date
August 14, 2035
Company
Karyopharm Therapeutics Inc. (KPTI)
Drug
SELINEXOR
BioSniper AIPage evidence connected

Prepared research question

What could this event change, and which evidence should be watched next?

Run cited research

Traceable citations · Unknowns marked

Patent Expiry

XPOVIO: recorded patent 10519139 expiry

Orange Book application NDA212306, product 005, listed patent 10519139 expiry. Overall loss of exclusivity and current company rights: unknown.FDA source